187 related articles for article (PubMed ID: 34107188)
1. Diffuse Large B-Cell Lymphoma.
Lang R; Gill MJ
N Engl J Med; 2021 Jun; 384(23):2261-2262. PubMed ID: 34107188
[No Abstract] [Full Text] [Related]
2. Simultaneous Presence of Follicular Lymphoma, Diffuse Large B-cell Lymphoma, and Hodgkin-like Lymphoma.
Papoudou-Bai A; Marinos L; Papathanasiou K; Kanavaros P; Kapsali E
Turk J Haematol; 2018 Nov; 35(4):308-309. PubMed ID: 30398157
[No Abstract] [Full Text] [Related]
3. Diffuse Large B-Cell Lymphoma. Reply.
Sehn LH; Salles G
N Engl J Med; 2021 Jun; 384(23):2262. PubMed ID: 34107189
[No Abstract] [Full Text] [Related]
4. IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children's Oncology Group trials.
Chisholm KM; Mohlman J; Liew M; Termuhlen A; Cairo MS; Gross TG; Perkins SL; Miles RR
Pediatr Blood Cancer; 2019 Aug; 66(8):e27770. PubMed ID: 31012208
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of ABT-199 (GDC-0199) in patients with relapsed/refractory non-Hodgkin lymphoma: responses observed in diffuse large B-cell (DLBCL) and follicular lymphoma (FL) at higher cohort doses.
Clin Adv Hematol Oncol; 2014 Aug; 12(8 Suppl 16):18-9. PubMed ID: 25768998
[No Abstract] [Full Text] [Related]
6. Perfusion and flow extraction product as potential discriminators in untreated follicular and diffuse large B cell lymphomas using volume perfusion CT with attempt at histopathologic explanation.
Spira D; Adam P; Linder C; Spira SM; Pintoffl J; Claussen CD; Horger M
AJR Am J Roentgenol; 2012 Jun; 198(6):1239-46. PubMed ID: 22623535
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.
Borovecki A; Korać P; Nola M; Ivanković D; Jaksić B; Dominis M
Croat Med J; 2008 Oct; 49(5):625-35. PubMed ID: 18925696
[TBL] [Abstract][Full Text] [Related]
8. Natural history of follicular grade 3 non-Hodgkin's lymphoma.
Bierman PJ
Curr Opin Oncol; 2007 Sep; 19(5):433-7. PubMed ID: 17762566
[TBL] [Abstract][Full Text] [Related]
9. Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma.
Tilly H; Morschhauser F; Salles G; Casasnovas RO; Feugier P; Molina TJ; Jardin F; Terriou L; Haioun C; Coiffier B
Leukemia; 2013 Jan; 27(1):252-5. PubMed ID: 22733106
[No Abstract] [Full Text] [Related]
10. [Occurrence of follicular small cleaved cell lymphoma following chemotherapy for diffuse large cell lymphoma].
Saito S; Hayashi K; Ohnoshi T; Kawashima K; Matsutomo S; Tagawa S; Yoshino T; Nishiuchi R; Kimura I
Rinsho Ketsueki; 1994 Jul; 35(7):676-81. PubMed ID: 8065020
[TBL] [Abstract][Full Text] [Related]
11. Comment on "Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial".
Vassilakopoulos TP; Apostolidis J; Angelopoulou MK
Haematologica; 2015 Nov; 100(11):e480-1. PubMed ID: 26521298
[No Abstract] [Full Text] [Related]
12. Physical activity, obesity and survival in diffuse large B-cell and follicular lymphoma cases.
Boyle T; Connors JM; Gascoyne RD; Berry BR; Sehn LH; Bashash M; Spinelli JJ
Br J Haematol; 2017 Aug; 178(3):442-447. PubMed ID: 28466570
[TBL] [Abstract][Full Text] [Related]
13. Economic burden and treatment patterns for patients with diffuse large B-cell lymphoma and follicular lymphoma in the USA.
Ren J; Asche CV; Shou Y; Galaznik A
J Comp Eff Res; 2019 Apr; 8(6):393-402. PubMed ID: 30855175
[TBL] [Abstract][Full Text] [Related]
14. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.
Jaime-Pérez JC; Gamboa-Alonso CM; Vázquez-Mellado de Larracoechea A; Rodríguez-Martínez M; Gutiérrez-Aguirre CH; Marfil-Rivera LJ; Gómez-Almaguer D
Arch Med Res; 2015 Aug; 46(6):454-61. PubMed ID: 26235285
[TBL] [Abstract][Full Text] [Related]
15. Response to comment by P. Vassilakopoulos and colleagues.
Jaeger U; Praxmarer M; Greil R;
Haematologica; 2015 Nov; 100(11):e482. PubMed ID: 26521299
[No Abstract] [Full Text] [Related]
16. Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.
Wendum D; Sebban C; Gaulard P; Coiffier B; Tilly H; Cazals D; Boehn A; Casasnovas RO; Bouabdallah R; Jaubert J; Ferrant A; Diebold J; de Mascarel A; Gisselbrecht C
J Clin Oncol; 1997 Apr; 15(4):1654-63. PubMed ID: 9193366
[TBL] [Abstract][Full Text] [Related]
17. CD10 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles.
Almasri NM; Iturraspe JA; Braylan RC
Arch Pathol Lab Med; 1998 Jun; 122(6):539-44. PubMed ID: 9625422
[TBL] [Abstract][Full Text] [Related]
18. Combination of Ibrutinib and ABT-199 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma.
Kuo HP; Ezell SA; Schweighofer KJ; Cheung LWK; Hsieh S; Apatira M; Sirisawad M; Eckert K; Hsu SJ; Chen CT; Beaupre DM; Versele M; Chang BY
Mol Cancer Ther; 2017 Jul; 16(7):1246-1256. PubMed ID: 28428442
[TBL] [Abstract][Full Text] [Related]
19. Survival outcomes of diffuse large B-cell lymphoma by association with concurrent or antecedent follicular lymphoma and double hit status.
Behdad A; Boddy CS; Fought AJ; Taxter T; Falkiewicz MK; Ayers E; Chen QC; Chen YH; Karmali R; Pro B; Winter JN; Landsburg DJ; Gordon LI; Kaplan JB
Leuk Lymphoma; 2019 Dec; 60(13):3266-3271. PubMed ID: 31225766
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous B-cell lymphomas: part II. Therapy and future directions.
Suárez AL; Querfeld C; Horwitz S; Pulitzer M; Moskowitz A; Myskowski PL
J Am Acad Dermatol; 2013 Sep; 69(3):343.e1-11; quiz 355-6. PubMed ID: 23957985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
